stockrowNature's Sunshine Products, Inc.
NATR Consumer Defensive Packaged Foods
Nature's Sunshine Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $480.1 million, up 5.67% from fiscal 2024.
- Revenue
- −9.14%
- EPS
- −63.3%
- Free cash flow
- −45.1%
Quarter to September 2026, against a year earlier
Follow NATR
Alert me
Nature's Sunshine Products, Inc. (NATR) EV/Sales
As of 5 November 2026, Nature's Sunshine Products, Inc. (NATR) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.2× (November 2026) to 0.9× (March 2026) — the current reading is the lowest in ten years. That is below the Packaged Foods industry median of 1.0× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.6× | 47.25% |
| FY2024 | 0.4× | (30.07%) |
| FY2023 | 0.6× | 112.33% |
| FY2022 | 0.3× | (55.56%) |
| FY2021 | 0.6× | 20.74% |
| FY2020 | 0.5× | 31.67% |
| FY2019 | 0.4× | 36.17% |
| FY2018 | 0.3× | (46.86%) |
| FY2017 | 0.6× | (23.96%) |
| FY2016 | 0.7× | 51.77% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 0.3× | (54.86%) |
| Jun 2026 | 0.6× | (8.44%) |
| Mar 2026 | 0.7× | 10.57% |
| Dec 2025 | 0.6× | 62.26% |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ENHA Enhanced Group Inc. compare | n/m |
| USNA USANA Health Sciences, Inc. compare | 0.2× |
| NATR Nature's Sunshine Products, Inc. | 0.2× |
| BRCC BRC Inc. compare | 0.3× |
| NAGE Niagen Bioscience, Inc. compare | 0.8× |
| OTLY Oatly Group AB Sponsored ADR compare | 0.8× |
| BGS B&G Foods, Inc. compare | 1.2× |
| LWAY Lifeway Foods, Inc. compare | 1.5× |
| PRE Prenetics Global Limited compare | 1.5× |
| Packaged Foods industry median | 1.0× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)